GRAVINA, Antonietta Gerarda
 Distribuzione geografica
Continente #
EU - Europa 10.648
AS - Asia 4.618
NA - Nord America 4.519
SA - Sud America 711
AF - Africa 77
OC - Oceania 12
Totale 20.585
Nazione #
RU - Federazione Russa 7.272
US - Stati Uniti d'America 4.426
SG - Singapore 1.642
CN - Cina 1.004
IT - Italia 922
IE - Irlanda 850
HK - Hong Kong 642
VN - Vietnam 604
BR - Brasile 577
GB - Regno Unito 317
DE - Germania 303
UA - Ucraina 285
KR - Corea 213
FR - Francia 150
FI - Finlandia 121
IN - India 121
JP - Giappone 116
SE - Svezia 102
TR - Turchia 72
NL - Olanda 65
GR - Grecia 56
AT - Austria 53
AR - Argentina 47
PL - Polonia 42
IQ - Iraq 36
MX - Messico 35
CA - Canada 33
ES - Italia 32
BD - Bangladesh 28
EC - Ecuador 25
BE - Belgio 22
ZA - Sudafrica 22
PK - Pakistan 20
ID - Indonesia 17
CO - Colombia 15
AZ - Azerbaigian 14
MA - Marocco 14
PY - Paraguay 13
VE - Venezuela 13
AU - Australia 11
UZ - Uzbekistan 10
PH - Filippine 9
IR - Iran 8
LT - Lituania 8
PE - Perù 8
CZ - Repubblica Ceca 7
EG - Egitto 7
JM - Giamaica 7
AL - Albania 6
BO - Bolivia 6
KE - Kenya 6
MY - Malesia 6
TH - Thailandia 6
JO - Giordania 5
PT - Portogallo 5
SA - Arabia Saudita 5
TN - Tunisia 5
KZ - Kazakistan 4
LV - Lettonia 4
SN - Senegal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MK - Macedonia 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
KH - Cambogia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 20.570
Città #
Moscow 2.598
Dublin 843
Singapore 765
Hong Kong 624
Santa Clara 615
San Jose 603
Chandler 442
Jacksonville 419
Naples 333
Ashburn 244
Seoul 209
Hefei 198
Ho Chi Minh City 191
Beijing 174
Hanoi 138
New York 111
Princeton 105
Los Angeles 97
Munich 84
Roxbury 84
Bengaluru 78
Boardman 76
Ann Arbor 71
Cambridge 58
The Dalles 58
Medford 54
Bremen 53
Dallas 51
Wilmington 47
São Paulo 44
Amsterdam 41
Woodbridge 41
Orem 40
Da Nang 38
Caserta 37
Haiphong 32
Nuremberg 31
Vienna 29
Rome 26
Tokyo 25
Des Moines 24
Dong Ket 24
Kraków 24
San Mateo 24
Turku 24
Aversa 23
Council Bluffs 23
Brussels 22
Nanjing 22
Paris 22
Helsinki 21
San Francisco 21
Mountain View 19
Napoli 19
Duhok 16
Guangzhou 16
Manchester 16
Boydton 15
Johannesburg 15
Milan 15
Porto Alegre 15
Frankfurt am Main 14
Jinan 14
Warsaw 14
Atlanta 13
Baku 13
Brooklyn 12
Curitiba 12
Hải Dương 12
Ninh Bình 12
Quito 12
Shenyang 12
Chicago 11
Lappeenranta 11
London 11
Montreal 11
Shanghai 11
Belo Horizonte 10
Biên Hòa 10
Mexico City 10
Mumbai 10
Stockholm 10
Tashkent 10
Angers 9
Boston 9
Buffalo 9
Campinas 9
Falkenstein 9
Houston 9
Lahore 9
Pagani 9
Secaucus 9
Seville 9
Viterbo 9
Atella 8
Bến Tre 8
Chennai 8
Pomezia 8
Seattle 8
Sennori 8
Totale 10.629
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 208
Intrafamilial spread of Helicobacter pylori infection 192
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 179
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 177
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 176
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 176
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 175
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 171
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 171
Crohn’s disease and skin 168
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 164
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 163
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 161
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 158
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 158
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 157
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 156
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 155
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 155
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 153
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 152
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin 152
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study 151
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 151
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 151
CARDIAC PACEMAKER AND WIRELESS CAPSULE ENDOSCOPY INTERFERENCE: CASE REPORT IN A PATIENT WITH GASTRIC VASCULAR ECTASIAS 150
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 150
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 150
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 150
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and Females 149
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 148
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 146
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 146
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 146
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 145
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 145
Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa 144
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study 144
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 143
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 143
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 142
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 142
Caso di interferenza tra video capsula e pacemaker in paziente portatore di pacemaker per aritmia 142
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 141
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 140
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 140
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 139
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 139
A randomized controlled trial of acarbose in hepatic encephalopathy 139
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 139
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 138
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 138
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 138
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 136
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 136
Ulcerative colitis associated with leukocytoclastic vasculitis of the skin 135
Light alcohol drinking and the risk of cancer development: a controversial relationship 135
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 134
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 133
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson 132
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 132
Inflammatory Bowel Diseases: The Role of Gut Microbiota 132
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 131
Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study 130
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 130
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 130
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 129
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 127
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 127
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 126
The burden of anaemia in patients with inflammatory bowel diseases 125
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis 125
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 124
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 124
Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? 124
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 122
Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the "BE-FIT-IBD" study 121
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 121
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 121
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 121
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 120
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments 120
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. 119
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 119
Extra-Gastric Manifestations of Helicobacter pylori Infection 118
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 117
Peptide Hp(2–20) accelerates healing of TNBS-induced colitis in the rat 116
Cyclic vomiting in a young patient with superior mesenteric artery syndrome 116
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 115
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 114
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 114
Impact of Helicobacter pylori Eradication on Inflammatory Bowel Disease Onset and Disease Activity: To Eradicate or Not to Eradicate? 113
Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey from the Italian society of endoscopic surgery and new technologies (SICE), the Italian society of digestive endoscopy (SIED), the world society of emergency surgery-Italy chapter (WSESit), and the Italian society of surgical endoscopy and digestive diseases (ISSE) 113
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 113
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 112
Author's reply: “Assessing ChatGPT and perplexity AI performance” 111
Sequential therapy for eradication of Helicobacter pilori infection 110
Infezione da Helicobacter pylori: fisiopatologia e clinica 110
Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs 109
Cutaneous Kaposi's Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding 109
Totale 13.897
Categoria #
all - tutte 63.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 97 81 44
2021/2022770 35 5 8 33 200 9 53 24 35 45 116 207
2022/20231.726 138 58 30 158 201 129 11 114 800 21 35 31
2023/2024932 57 38 43 64 240 113 28 17 7 40 96 189
2024/20253.154 20 46 83 138 503 430 414 243 450 347 259 221
2025/202612.440 529 734 685 569 1.036 6.787 799 644 402 255 0 0
Totale 20.899